June 2026 at the London Institute for Healthcare Engineering

At LIHE, we are dedicated to helping bring MedTech innovations to life with real benefits to clinicians and patients. We are already home to companies and spinouts including Siemens Healthineers, NVIDIA, Fraiya and Hypervision Surgical, and now, we are opening our doors even wider with our new membership packages.

The packages give members flexible access to our facilities and ecosystem of MedTech entrepreneurs, including hotdesking, onsite reception and security, printing, room booking, and events (depending on package). Whether you need a touchdown space for an afternoon, a few days a week, or full-time access, you’ll be working alongside others navigating the realities of building a MedTech venture.

Find out more by contacting lihe.ops@kcl.ac.uk

The UK’s draft Medical Devices (Amendment) Regulations 2026, recently published via the World Trade Organization, mark a key step in modernising the national regulatory framework. The proposals introduce enhanced pre-market requirements for medical devices in Great Britain, aiming to strengthen patient safety while supporting innovation.

Changes are expected to include updated conformity assessment pathways, increased scrutiny for higher-risk devices, and clearer evidence requirements for market approval. The reforms also seek to align, where appropriate, with international standards while maintaining UK regulatory autonomy.

Adoption is anticipated in December 2026, followed by a phased implementation period to allow manufacturers and stakeholders time to prepare for compliance with the new arrangements.

You can read a summary of the changes here.

After a highly competitive process, we are pleased to announce 11 ventures have been selected for the third cohort of the MedTech Venture Builder. Congratulations to Joyvié Health Ltd, Slippery Saints, Omnilabs Research, Revive Innovations +, Mentalio, Pacora (Patient Controlled Oral Analgesia), NOMW Health, Veren Surgical, Eye2Gene, Arcus Imaging and Kavi Nova.This diverse cohort is addressing some of the most pressing challenges in healthcare, with innovations ranging from a rapid, single-use haemorrhage autoinjector to digital mental health solutions, overdose-detecting wearables and at-home dental imaging technologies. We look forward to supporting their progress over the next 12 months, as they develop impactful, scalable solutions for patients and healthcare systems.

We are delighted to welcome the third cohort of the King’s MedTech Accelerator, with 25 projects across King’s College London, King’s Health Partners, NIHR HRC Brain Health and the Royal College of Surgeons. Innovations range from surgical devices to wearable monitoring and AI-powered diagnostics, tackling conditions from neonatal care to Alzheimer’s disease.

Over the next six months, participants will take part in expert-led masterclasses on IP, regulatory pathways, healthcare economics, market access and investor readiness, alongside 1:1 mentorship. Previous cohorts have progressed to translational grants, patent filings and spinout-formation.

Read more

ScubaTx and PeriPear from our MedTech Venture Kickstarter programme were both named winners of the ClimbUK National Innovation Competition, sponsored by Barclays UK Innovation Banking. ScubaTx is developing a novel organ preservation device, while PeriPear is developing a wearable device that reduces the risk of tearing during childbirth. PeriPear also took first place at the NatWest Accelerator Pitch Oxford final earlier this month, winning £70,000 in grant funding.

Cardiovolt.ai, from our MedTech Venture Kickstarter programme, has raised £1.4m in pre-seed funding to commercialise AI models that extract diagnostic insights from standard ECG traces, detecting hidden heart conditions and predicting patient risk from a routine ten-second heart trace. The round was led by Twin Path Ventures, with backing from the Pioneer Group.

Neubond, from our MedTech Venture Builder programme, has raised £1.5m in seed funding to bring their wearable stroke rehabilitation platform to patients, with a 30% improvement in range of motion shown in an initial pilot. The round was led by Tokyo-based deep tech investor WASEDA University Ventures with participation from SFC Capital and New Wave Ventures. This marks WASEDA University Ventures' first-ever investment in a UK startup.

Congratulations to all our alumni ventures!

Last week, we proudly hosted the inaugural Women at Scale event - a new, collaborative initiative from LIHE and our industry partners at Siemens Healthineers, aimed at building a women-focused community spanning innovation and leadership in MedTech. The think-tank brought together professionals from startups, industry, academia and clinical care for an afternoon of honest conversation and shared ambition.

Highlights included:

• How LIHE’s ecosystem helps women-led MedTech ventures move from bench to bedside.

• How Siemens Healthineers is advancing female representation and leadership through its #StepUp network.

• A panel on women in MedTech - leading diverse teams, women-centred innovation and community co-creation - featuring SONA’s Jane Ollis, LIHE’s Valentina Vitiello, Ana Raduc and Siemens Healthineers’ Gill Coughlan.

Thank you to everyone who joined us, and to our organising committee – Antoinette Cameron-Pimblett, Jane Ollis and Giulia Ginami – for bringing this initiative to life. This is just the beginning: Women at Scale will continue to convene our community and turn ambition into action.